Researchers in California report development of an anti-cancer “warhead” that targets the acidic signature of tumor cells in much the same way that heat-seeking missiles seek and destroy military targets that emit heat. These acid-seeking substances are not toxic to healthy cells, and represent a new class of potentially safer, more effective anti-cancer drugs, they say. Their study is scheduled for the March 6 issue of ACS’ The Journal of Physical Chemistry B.
For years, scientists tried to develop anti-cancer drugs based on enediynes, a powerful class of natural, tumor-fighting agents derived from soil bacteria. However, as these substances kill both cancerous and healthy cells, their effectiveness as anti-cancer drugs is limited.
In the new study, Elfi Kraka and colleagues describe making unusual substances that become highly active only in the presence of low pH levels, or acidic environments. Since cancer cells have highly acidic environments in comparison to normal cells, compounds containing these substances — called dynemicin-amidines (DADs) — target and destroy tumor cells without affecting healthy cells, the researchers say. The substances represent “the design of the first nontoxic enediyne antitumor drugs based on the DAD principle,” the report states.
Source: American Chemical Society
Related stories:
FSU researcher using computers to hone cancer-fighting strategies
A Florida State University faculty member who uses computational techniques to evaluate a new class of cancer-killing drugs is attracting worldwide attention from other researchers.
Nano-sized technology has super-sized effect on tumors
Anyone facing chemotherapy would welcome an advance promising to dramatically reduce their dose of these often harsh drugs. Using nanotechnology, researchers at Washington University School of Medicine in St. Louis have taken a step closer to that goal.
Study refutes belief that black men have more aggressive prostate cancer
A University of Minnesota study of prostate cancer tumors from Caucasian and African-American men has shown no evidence that the cancer is more aggressive in black men. Lead investigator Akhouri Sinha, a professor of genetics, cell biology, and development and research scientist at the Minneapolis VA Medical Center, said the belief that black men’s tumors are more aggressive is based on studies that failed to match patients properly and used only indirect means to measure tumor aggressiveness. The work will be published in
Anticancer Research Sept. 21 (vol. 27, issue 5A, pp. 3135-3142).
Chemicals in brown algae may protect against skin cancer
Substances extracted from a marine seaweed may protect against skin cancer caused by too much sun, new research suggests.
Vitamin D a key player in overall health of several body organs, says UC Riverside biochemist
Essential for life in higher animals, vitamin D, once linked to only bone diseases such as rickets and osteoporosis, is now recognized as a major player in contributing to overall human health, emphasizes UC Riverside's Anthony Norman, an international expert on vitamin D.
Do 'light' cigarettes deliver less nicotine to the brain than regular cigarettes?
For decades now, cigarette makers have marketed so-called light cigarettes — which contain less nicotine than regular smokes — with the implication that they are less harmful to smokers' health. A new UCLA study shows, however, that they deliver nearly as much nicotine to the brain.
Hybrid Nanoparticles Image and Treat Tumors
(PhysOrg.com) -- By combining a magnetic nanoparticle, a fluorescent quantum dot, and an anticancer drug within a lipid-based nanoparticle, a multi-institutional research team headed by members of the National Cancer Institute’s (NCI) Alliance for Nanotechnology in Cancer has created a single agent that can image and treat tumors. In addition, this new nanoparticle is able to avoid detection by the immune system, enabling the particle to remain in the body for extended periods of time.
Feeding your body's defenses against cancer
David Servan-Schreiber was 31 when he was diagnosed with a walnut-size brain tumor and given 6 months to live. After surgery and chemotherapy, the young neuroscientist asked his oncologist if he should change his diet.